{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:51:11Z","timestamp":1792839071368,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10620-025-09130-8","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T21:57:00Z","timestamp":1749592620000},"page":"3157-3164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In-Hospital Outcomes of Patients with Hepatorenal Syndrome Who Underwent Transjugular Intrahepatic Portosystemic Shunt Procedure"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1691-6278","authenticated-orcid":false,"given":"Renxi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SeungEun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Tsavaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn N.","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"9130_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.15386\/cjmed-847","volume":"90","author":"G Testino","year":"2017","unstructured":"Testino G. Hepatorenal syndrome: role of the transjugular intrahepatic stent shunt in real life practice. Clujul Medical 2017;90:464. https:\/\/doi.org\/10.15386\/cjmed-847.","journal-title":"Clujul Medical"},{"key":"9130_CR2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/hep.510230122","volume":"23","author":"V Arroyo","year":"1996","unstructured":"Arroyo V, Gin\u00e8s P, Gerbes AL et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996;23:164\u2013176. https:\/\/doi.org\/10.1002\/hep.510230122.","journal-title":"International Ascites Club. Hepatology"},{"key":"9130_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2008.02.012","volume":"119","author":"PA McCormick","year":"2008","unstructured":"McCormick PA, Donnelly C. Management of hepatorenal syndrome. Pharmacology & Therapeutics 2008;119:1\u20136. https:\/\/doi.org\/10.1016\/j.pharmthera.2008.02.012.","journal-title":"Pharmacology & Therapeutics"},{"key":"9130_CR4","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1136\/gut.2009.193227","volume":"59","author":"M R\u00f6ssle","year":"2010","unstructured":"R\u00f6ssle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut 2010;59:988\u20131000. https:\/\/doi.org\/10.1136\/gut.2009.193227.","journal-title":"Gut"},{"key":"9130_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1055\/s-0042-1748818","volume":"07","author":"SSR Vulasala","year":"2023","unstructured":"Vulasala SSR, Onteddu NKR, Kalva SP, Smolinski-Zhao S. Expanding indications of TIPS in the management of portal hypertension complications. J Clin Int Radiol ISVIR 2023;07:34\u201345. https:\/\/doi.org\/10.1055\/s-0042-1748818.","journal-title":"J Clin Int Radiol ISVIR"},{"key":"9130_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.dld.2018.01.123","volume":"50","author":"T Song","year":"2018","unstructured":"Song T, R\u00f6ssle M, He F et al. Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: a systematic review and meta-analysis. Dig Liver Dis 2018;50:323\u2013330. https:\/\/doi.org\/10.1016\/j.dld.2018.01.123.","journal-title":"Dig Liver Dis"},{"key":"9130_CR7","volume-title":"StatPearls","author":"NB Amesur","year":"2023","unstructured":"Amesur NB, Novelli P. Transjugular intrahepatic portosystemic shunt. In Treasure Island: StatPearls Publishing; 2023."},{"key":"9130_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1055\/s-0034-1382790","volume":"31","author":"A Copelan","year":"2014","unstructured":"Copelan A, Kapoor B, Sands M. Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. Semin Intervent Radiol 2014;31:235\u2013242. https:\/\/doi.org\/10.1055\/s-0034-1382790.","journal-title":"Semin Intervent Radiol"},{"key":"9130_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/lt.500020210","volume":"2","author":"N Jabbour","year":"1996","unstructured":"Jabbour N, Zajko AB, Orons PD et al. Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients. Liver Transpl 1996;2:139\u2013147. https:\/\/doi.org\/10.1002\/lt.500020210.","journal-title":"Liver Transpl"},{"key":"9130_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S1665-2681(19)32033-2","volume":"5","author":"F Wong","year":"2006","unstructured":"Wong F. The use of TIPS in chronic liver disease. Ann Hepatol 2006;5:5\u201315. https:\/\/doi.org\/10.1016\/S1665-2681(19)32033-2.","journal-title":"Ann Hepatol"},{"key":"9130_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.iliver.2023.02.001","volume":"2","author":"H Wang","year":"2023","unstructured":"Wang H, Liu F. Clinical characteristics of hepatopulmonary syndrome and hepatorenal syndrome and associated therapeutic potential of transjugular intrahepatic portosystemic shunt. iLIVER 2023;2:67\u201372. https:\/\/doi.org\/10.1016\/j.iliver.2023.02.001.","journal-title":"iLIVER"},{"key":"9130_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/qjmed\/hcn037","volume":"101","author":"S Masson","year":"2008","unstructured":"Masson S, Mardini HA, Rose JD, Record CO. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience. QJM: An Int J Med 2008;101:493\u2013501. https:\/\/doi.org\/10.1093\/qjmed\/hcn037.","journal-title":"QJM: An Int J Med"},{"key":"9130_CR13","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jhep.2023.11.033","volume":"80","author":"S Nardelli","year":"2024","unstructured":"Nardelli S, Riggio O, Marra F et al. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis. J Hepatol 2024;80:596\u2013602. https:\/\/doi.org\/10.1016\/j.jhep.2023.11.033.","journal-title":"J Hepatol"},{"key":"9130_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011039.pub2","author":"AG Gonzalez-Garay","year":"2024","unstructured":"Gonzalez-Garay AG, Serralde-Z\u00fa\u00f1iga AE, Hidalgo LV et al. Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome. Cochrane Database Syst Rev. 2024. https:\/\/doi.org\/10.1002\/14651858.CD011039.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"9130_CR15","unstructured":"Healthcare Cost and Utilization Project (HCUP) NIS Notes. https:\/\/hcup-us.ahrq.gov\/db\/vars\/race\/nisnote.jsp. Accessed 27 Sep 2023"},{"key":"9130_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8\u201327. https:\/\/doi.org\/10.1097\/00005650-199801000-00004.","journal-title":"Med Care"},{"key":"9130_CR17","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/hep.22676","volume":"49","author":"RP Myers","year":"2009","unstructured":"Myers RP, Quan H, Hubbard JN et al. Predicting in-hospital mortality in patients with cirrhosis: results differ across risk adjustment methods. Hepatology 2009;49:568\u2013577. https:\/\/doi.org\/10.1002\/hep.22676.","journal-title":"Hepatology"},{"key":"9130_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jacr.2019.08.020","volume":"17","author":"PS Trivedi","year":"2020","unstructured":"Trivedi PS, Brown MA, Rochon PJ et al. Gender disparity in inpatient mortality after transjugular intrahepatic portosystemic shunt creation in patients admitted with hepatorenal syndrome: a nationwide study. J Am Coll Radiol 2020;17:231\u2013237. https:\/\/doi.org\/10.1016\/j.jacr.2019.08.020.","journal-title":"J Am Coll Radiol"},{"key":"9130_CR19","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.4254\/wjh.v8.i25.1075","volume":"8","author":"JP Arab","year":"2016","unstructured":"Arab JP, Claro JC, Arancibia JP et al. Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: a Delphi technique-based consensus. World J Hepatol 2016;8:1075\u20131086. https:\/\/doi.org\/10.4254\/wjh.v8.i25.1075.","journal-title":"World J Hepatol"},{"key":"9130_CR20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/s0140-6736(97)24010-9","volume":"349","author":"KA Brensing","year":"1997","unstructured":"Brensing KA, Textor J, Strunk H et al. Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome. Lancet 1997;349:697\u2013698. https:\/\/doi.org\/10.1016\/s0140-6736(97)24010-9.","journal-title":"Lancet"},{"key":"9130_CR21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/gut.47.2.288","volume":"47","author":"KA Brensing","year":"2000","unstructured":"Brensing KA, Textor J, Perz J et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000;47:288\u2013295. https:\/\/doi.org\/10.1136\/gut.47.2.288.","journal-title":"Gut"},{"key":"9130_CR22","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/hep.510280219","volume":"28","author":"M Guevara","year":"1998","unstructured":"Guevara M, Gin\u00e8s P, Bandi JC et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998;28:416\u2013422. https:\/\/doi.org\/10.1002\/hep.510280219.","journal-title":"Hepatology"},{"key":"9130_CR23","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1053\/he.2000.5852","volume":"31","author":"M Malinchoc","year":"2000","unstructured":"Malinchoc M, Kamath PS, Gordon FD et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864\u2013871. https:\/\/doi.org\/10.1053\/he.2000.5852.","journal-title":"Hepatology"},{"key":"9130_CR24","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.dld.2021.09.008","volume":"54","author":"P Ponzo","year":"2022","unstructured":"Ponzo P, Campion D, Rizzo M et al. Transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease: impact on renal function. Digestive Liver Dis 2022;54:1101\u20131108. https:\/\/doi.org\/10.1016\/j.dld.2021.09.008.","journal-title":"Digestive Liver Dis"},{"key":"9130_CR25","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1053\/gast.2002.37073","volume":"123","author":"P Gin\u00e8s","year":"2002","unstructured":"Gin\u00e8s P, Uriz J, Calahorra B et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002;123:1839\u20131847. https:\/\/doi.org\/10.1053\/gast.2002.37073.","journal-title":"Gastroenterology"},{"key":"9130_CR26","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","volume":"342","author":"M R\u00f6ssle","year":"2000","unstructured":"R\u00f6ssle M, Ochs A, G\u00fclberg V et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000;342:1701\u20131707. https:\/\/doi.org\/10.1056\/NEJM200006083422303.","journal-title":"N Engl J Med"},{"key":"9130_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13063-023-07261-9","volume":"24","author":"C Ripoll","year":"2023","unstructured":"Ripoll C, Platzer S, Franken P et al. Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis\u2014a randomized controlled trial. Trials 2023;24:258. https:\/\/doi.org\/10.1186\/s13063-023-07261-9.","journal-title":"Trials"},{"key":"9130_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1055\/s-0038-1660797","volume":"35","author":"J Chmielewski","year":"2018","unstructured":"Chmielewski J, Lewandowski RJ, Maddur H. Hepatorenal syndrome: physiology, diagnosis and management. Semin Intervent Radiol 2018;35:194\u2013197. https:\/\/doi.org\/10.1055\/s-0038-1660797.","journal-title":"Semin Intervent Radiol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09130-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09130-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09130-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T05:17:56Z","timestamp":1756963076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09130-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["9130"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09130-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was exempt from the IRB approval by The George Washington University as it analyzed retrospective, deidentified NIS data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}